Deans' stroke musings: Taking Stock of the Latest Research in Parkinson’s Disease Management: A Clinical Update From Washington, DC

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, June 2, 2015

Taking Stock of the Latest Research in Parkinson’s Disease Management: A Clinical Update From Washington, DC

Creating A CME for stroke is the absolute minimum that the ASA, NSA and WSO should be doing. But that won't occur under the current leadership.
http://peerviewpress.com/taking-stock-latest-research-parkinson%E2%80%99s-disease-management-clinical-update-washington-dc?

Activity Description & Educational Objectives

In this video-based activity, an expert in Parkinson’s disease (PD) discusses recently presented data on new and established treatment approaches for the management of motor symptoms and motor complications, as well as non–motor symptoms, in individuals with advanced PD.
Upon completion of this activity, participants should be better able to:

Apply new efficacy, safety, and tolerability data on approved therapies for the management of motor symptoms in patients with early Parkinson’s disease (PD)
Employ late-breaking efficacy, safety, and tolerability data on therapeutic strategies for the management of motor complications in patients with advanced PD
Assess recently presented data on the management of non–motor symptoms in patients with PD

Target Audience

This activity has been designed to meet the educational needs of neurologists and other clinicians involved in the management of PD.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.